Treace Medical Concepts, Inc.
NASDAQ:TMCI
8.04 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 187.118 | 141.838 | 94.419 | 57.365 | 39.416 |
| Cost of Revenue
| 35.181 | 27.523 | 17.826 | 12.47 | 7.631 |
| Gross Profit
| 151.937 | 114.315 | 76.593 | 44.895 | 31.785 |
| Gross Profit Ratio
| 0.812 | 0.806 | 0.811 | 0.783 | 0.806 |
| Reseach & Development Expenses
| 15.44 | 13.584 | 10.204 | 5.847 | 5.07 |
| General & Administrative Expenses
| 47.031 | 32.999 | 18.432 | 6.539 | 4.464 |
| Selling & Marketing Expenses
| 140.894 | 102.576 | 64.467 | 31.654 | 25.786 |
| SG&A
| 187.925 | 135.575 | 82.899 | 38.193 | 30.25 |
| Other Expenses
| 0.342 | -0.403 | 0.001 | 0 | 0 |
| Operating Expenses
| 203.365 | 149.159 | 93.103 | 44.04 | 35.32 |
| Operating Income
| -51.428 | -34.844 | -16.51 | -0.891 | -3.535 |
| Operating Income Ratio
| -0.275 | -0.246 | -0.175 | -0.016 | -0.09 |
| Total Other Income Expenses Net
| 1.901 | -7.971 | -4.042 | -2.777 | -0.73 |
| Income Before Tax
| -49.527 | -42.815 | -20.552 | -3.668 | -4.265 |
| Income Before Tax Ratio
| -0.265 | -0.302 | -0.218 | -0.064 | -0.108 |
| Income Tax Expense
| 5.184 | 4.483 | 4.06 | 2.777 | 0.841 |
| Net Income
| -49.527 | -47.298 | -24.612 | -6.445 | -5.106 |
| Net Income Ratio
| -0.265 | -0.333 | -0.261 | -0.112 | -0.13 |
| EPS
| -0.81 | -0.86 | -0.45 | -0.13 | -0.1 |
| EPS Diluted
| -0.81 | -0.86 | -0.45 | -0.13 | -0.1 |
| EBITDA
| -46.076 | -31.801 | -15.807 | 0.319 | -2.631 |
| EBITDA Ratio
| -0.246 | -0.224 | -0.167 | 0.006 | -0.067 |